Skip to main content

ERRATUM article

Front. Med., 07 February 2022
Sec. Ophthalmology
Volume 9 - 2022 | https://doi.org/10.3389/fmed.2022.857417
This article is part of the Research Topic Novel Diagnostic and Therapeutic Strategies for Retinal Diseases View all 42 articles

Erratum: Axl Is Essential for in-vitro Angiogenesis Induced by Vitreous From Patients With Proliferative Diabetic Retinopathy

This article is an erratum on:

  1. Axl Is Essential for in-vitro Angiogenesis Induced by Vitreous From Patients With Proliferative Diabetic Retinopathy

    1. Read original article
\n Frontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Axl Is Essential for in-vitro Angiogenesis Induced by Vitreous From Patients With Proliferative Diabetic Retinopathy

by Wu, W., Xu, H., Meng, Z., Zhu, J., Xiong, S., Xia, X., and Lei, H. (2021). Front. Med. 8:787150. doi: 10.3389/fmed.2021.787150

Due to a production error, there was an error in affiliations 1 and 4. Instead of “The Second Xiangya Hospital of Central South University,” it should be “Xiangya Hospital of Central South University.” The publisher apologizes for this mistake. The original version of this article has been updated.

Keywords: PDR vitreous, GAS6, Axl, CRISPR/Cas9, R428, HRECs

Citation: Frontiers Production Office (2022) Erratum: Axl Is Essential for in-vitro Angiogenesis Induced by Vitreous From Patients With Proliferative Diabetic Retinopathy. Front. Med. 9:857417. doi: 10.3389/fmed.2022.857417

Received: 18 January 2022; Accepted: 18 January 2022;
Published: 07 February 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.